Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty
Clinical trial NCT02982915 · COMPLETED
Trial details
- NCT number
- NCT02982915
- Sponsor
- Longeveron Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2021-09-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.